Waseda University
VC Fund
Tokyo, Japan
Waseda University is a Tokyo-based private university that offers various degree programs. As the second private university to be founded in Japan, Waseda University is considered to be one of Japan's most prestigious universities, consistently ranking amongst the top universities in Japanese university rankings. The University has manynotable alumni in Japan, with seven Prime Ministers of Japan and many CEOs, including Tadashi Yanai, the CEO of UNIQLO and wealthiest man in Japan.Waseda University's main campus is located in the Nishi-Waseda district of Shinjuku. Apart from the main campus in Shinjuku, It has other campuses around the country, including Toyama Campus and Nishi-Waseda Campus in Shinjuku; Nihonbashi Campus in Chuo-ku; Higashifushimi Campus in Nishitokyo; Tokorozawa Campus in Tokorozawa; Honjo Campus in Honjo, Saitama; and Kitakyushu Campus in Kitakyushu, Fukuoka.The university has more than fifty thousand students and staff, comprising 13 undergraduate schools, 23 graduate schools, and other research and affiliated institutes, and is one of the 13 universities in the Japanese Ministry of Education, Culture, Sports, Science and Technology's ""Global 30"" Project. It has partnerships with more than 600 universities and tertiary institutions, with many international students studying abroad at Waseda University each year.Established in 1882 as the Tōkyō College by Okuma Shigenobu, the school was renamed Waseda University in 1902 after the founder's hometown village.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Waseda University invests in
Stages Waseda University invests in
Countries Waseda University invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Social 1 (17%)
- FinTech 1 (17%)
- Big Data 1 (17%)
- Analytics 1 (17%)
- Therapeutics 1 (17%)
Stage
- Series A 2 (33%)
- Seed 1 (17%)
- Series B 1 (17%)
- Funding Round 1 (17%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Atsuo Nakayama
Lecturer
|
Lecturer | Total investments: 1 | Find email | |
Hiroki Matsuda
Visiting Researcher
|
Visiting Researcher | Total investments: 0 | Find email | |
|
Takeo Hirata
professor; Professor
|
professor; Professor | Total investments: 0 | Find email | |
Tatsuyuki Negoro
Professor
|
Professor | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Zuva
|
Zuva KK provides an information platform dedicated to overseas startups based on the project. | $736.1K / Seed / Oct 16, 2019 | |
ZAISAN Net
|
ZAISAN Net is the well-known leading AI-Fintech startup in Japan, specializing in handling time-series of data like stock price movements. Institutional investors benefit from ZAISAN Net’s AI forecast signals and alerts while consumers have access to Kabuto-yohou, the stock forecast from wall-street in Japan, which is already popular and has beenintroduced on World Business Satellite, TV program similar to CNN. | Series A / May 17, 2016 | |
SymBio Pharmaceuticals
|
SymBio Pharmaceuticals Limited operates as a biopharmaceutical company. It offers Symbenda medicine for treating low-grade non-Hodgkin's lymphoma and chronic lymphatic leukemia in Singapore. The company was founded in 2005 and is headquartered in Tokyo, Japan. | $78M / May 10, 2010 | |
|
SymBio Pharmaceuticals
|
SymBio Pharmaceuticals Limited operates as a biopharmaceutical company. It offers Symbenda medicine for treating low-grade non-Hodgkin's lymphoma and chronic lymphatic leukemia in Singapore. The company was founded in 2005 and is headquartered in Tokyo, Japan. | $311.8M / Dec 11, 2009 | |
Datasection
|
Datasection is a social big data company that provides various big data analysis tools for its clients. It specializes in marketing research, data provision and processing, image analysis, overseas SNS, and data utilization and optimization. Datasection was founded in 2000. | $6.9M / Series A / Dec 01, 2009 | |
|
SymBio Pharmaceuticals
|
SymBio Pharmaceuticals Limited operates as a biopharmaceutical company. It offers Symbenda medicine for treating low-grade non-Hodgkin's lymphoma and chronic lymphatic leukemia in Singapore. The company was founded in 2005 and is headquartered in Tokyo, Japan. | $283.5M / Series B / Jun 27, 2006 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Waseda University invest in?
Waseda University invests primarily in Social, FinTech and Big Data startups, most often at Series A and Seed stage. Most of the 6 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Waseda University?
Public channels for Waseda University include X (Twitter), the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Waseda University?
The team at Waseda University includes Atsuo Nakayama (Lecturer), Hiroki Matsuda (Visiting Researcher) and Takeo Hirata (professor; Professor). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
